TheEdgeResearch
Home / Stocks / FEED

ENvue Medical, Inc. (FEED)

NASDAQ Healthcare Medical - Specialties
$0.39 ▼ -1.10%
Market Cap
$3.7M
Sector
Healthcare
Industry
Medical - Specialties
Beta
1.56
52-Wk Range
0.2903-5.98
CEO
Doron Robert Besser
Country
US
Currency
USD

ENvue Medical, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Tyler, TX, US. The stock last traded at $0.39, down 1.10% on the session, giving a market capitalisation of $3.7M. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -744.2%. Its beta of 1.56 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
1.68
Price / Book
0.00
EV / EBITDA
-0.21
Gross margin
-12.4%
Operating margin
-623.3%
Net margin
-744.2%
Return on equity
Debt / equity
0.04
Current ratio
0.90
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
13
IPO date
2025-12-12
Headquarters
Tyler, TX, US
About ENvue Medical, Inc.

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.

More research on FEED
FEED technical analysis FEED TheEdge Score Compare against peers
Open full interactive analysis & DCF →